Biotechnology and precision medicine company Caris Life Sciences announced it raised $168 million in growth capital funding.
Caris Life Sciences has now raised $1.86 billion in capital since 2018.
Braidwell LP led the round with participation from new investors Perceptive Advisors, Woodline and Ghisallo.
Millennium Management and First Light Asset Management also participated in the round.
WHAT...
Tempus, an AI-powered data company involved in advancing precision medicine, launched olivia, an AI-enabled personal health concierge app aimed to empower patients by centralizing patients’ health data and making that data accessible and actionable through AI.
The app will allow patients to bring their health information into one combined platform.
Additionally, patients will be able to connect...
Atropos Health, a company translating real-world clinical data into real-world evidence (RWE) for decision making, is partnering with xCures, an AI-powered healthcare data retrieval company, to harness RWE-based insights to support patient care.
The aim of the partnership is to leverage AI, the Atropos Evidence Network and the xCures Platform in order to "develop and deploy validated prognostic...
ImpriMed, a precision medicine company, announced that it has expanded its services to include human oncology.
The aim is to provide drug-response predictions for routine blood cancers such as newly diagnosed multiple myeloma and acute myeloid leukemia.
ImpriMed's human precision medicine services will set their sights on complex blood cancers via a combination of genomic analysis, ex vivo drug...
Hackensack Meridian Health announced it launched a cancer risk and early detection program at the health system’s Hennessy Institute for Cancer Prevention and Applied Molecular Medicine in partnership with oncology-focused precision health technology company CancerIQ, aimed at improving early diagnosis, treatment and prevention.
The program integrates advanced technology, genomics and AI into...
Octave Bioscience, a company focused on delivering precision medicine for neurodegenerative diseases like multiple sclerosis, announced it closed a $30 million extension to its Series B round.
Hikma Pharmaceuticals' venture capital arm, Hikma Ventures, participated in the round alongside Novartis (dRx Capital) and Intermountain Ventures. Existing investors Echo Health Ventures, Deerfield...
Healthcare data company ConcertAI announced its expanded partnership with Caris Life Sciences, where the companies will jointly create a database to generate insights to advance precision medicine, clinical trial management and therapeutic development.
ConcertAI is a real-world data and AI company for healthcare providers and life science companies, while Caris Life Sciences offers whole exome...
CHICAGO – Implementing precision medicine programs could allow health systems to diagnose disease more quickly or predict a patient's response to a specific mediation, said panelists at the 2023 HIMSS Global Health Conference & Exhibition.
But there are challenges to putting together an effective genomics program, said Jackie Rice, vice president for information technology and chief...
Health research platform maker Vibrent Health announced last week that it has received a $39 million infusion from the National Institutes of Health to continue serving as the hub of the public research organization's All of Us Research Program.
Founded in 2009, Vibrent Health's technology handles large-scale data collection, storage, analysis and security for research organizations, and includes...
Sema4, a Mount Sinai spinout developing health-data-analytics platforms, has raised $121 million in Series C funding. BlackRock led the oversubscribed round, which also saw participation from new investors Deerfield Management Company and Moore Strategic Ventures, and also old backers Blackstone, Section 32, Oak HC/FT, Decheng and Connecticut Innovations.
With this round, coming less than a year...
